BRPI0418879A - formulação de dosagem por agente de constrate pelo ultra-som - Google Patents

formulação de dosagem por agente de constrate pelo ultra-som

Info

Publication number
BRPI0418879A
BRPI0418879A BRPI0418879-9A BRPI0418879A BRPI0418879A BR PI0418879 A BRPI0418879 A BR PI0418879A BR PI0418879 A BRPI0418879 A BR PI0418879A BR PI0418879 A BRPI0418879 A BR PI0418879A
Authority
BR
Brazil
Prior art keywords
microparticles
dosage formulation
dry powder
vial
body weight
Prior art date
Application number
BRPI0418879-9A
Other languages
English (en)
Portuguese (pt)
Inventor
Richard Walovitch
Howard Bernstein
Donald E Chickering Iii
Julie A Straub
Original Assignee
Acusphere Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acusphere Inc filed Critical Acusphere Inc
Publication of BRPI0418879A publication Critical patent/BRPI0418879A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/223—Microbubbles, hollow microspheres, free gas bubbles, gas microspheres

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Acoustics & Sound (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
BRPI0418879-9A 2004-06-04 2004-06-04 formulação de dosagem por agente de constrate pelo ultra-som BRPI0418879A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/017813 WO2005120587A1 (en) 2004-06-04 2004-06-04 Ultrasound contrast agent dosage formulation

Publications (1)

Publication Number Publication Date
BRPI0418879A true BRPI0418879A (pt) 2007-11-27

Family

ID=34958128

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418879-9A BRPI0418879A (pt) 2004-06-04 2004-06-04 formulação de dosagem por agente de constrate pelo ultra-som

Country Status (10)

Country Link
JP (1) JP4808214B2 (zh)
CN (1) CN1993147B (zh)
AU (1) AU2004320514B8 (zh)
BR (1) BRPI0418879A (zh)
CA (1) CA2569134C (zh)
IL (2) IL179594A (zh)
MX (1) MXPA06014111A (zh)
NO (1) NO20070070L (zh)
RU (1) RU2344833C2 (zh)
WO (1) WO2005120587A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9630028B2 (en) * 2006-08-11 2017-04-25 Koninklijke Philips N.V. Ultrasound system for cerebral blood flow imaging and microbubble-enhanced blood clot lysis
KR101061224B1 (ko) * 2008-10-08 2011-08-31 포항공과대학교 산학협력단 Ｘ 선을 이용한 유동정보 측정용 캡슐
US8784800B2 (en) 2009-03-09 2014-07-22 Medtronic, Inc. Method of delivering cell therapy to a target site
US9757462B2 (en) 2010-11-19 2017-09-12 Sapporo Medical University Combined pharmaceutical preparation
EP2844362B1 (en) * 2012-04-30 2020-02-26 Ge Healthcare As Method for filling a container with a foamable composition
ES2821966T3 (es) 2014-04-02 2021-04-28 Nitto Denko Corp Molécula de direccionamiento derivada de RBP y utilización de la misma
ES2890328T3 (es) * 2015-04-20 2022-01-18 Univ California Gas encapsulado o material de contraste de CT de vacío parcial
RU2620758C1 (ru) * 2016-07-13 2017-05-29 Федеральное государственное бюджетное научное учреждение "Научный центр неврологии" (ФГБНУ НЦН) Способ количественного определения микрососудов в атеросклеротической бляшке сонных артерий
CN111419181B (zh) * 2020-03-31 2023-07-25 浙江大学 一种用于小动物长时间活体成像的装置及其使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6146657A (en) * 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US5773024A (en) * 1989-12-22 1998-06-30 Imarx Pharmaceutical Corp. Container with multi-phase composition for use in diagnostic and therapeutic applications
CN1068229C (zh) * 1993-12-15 2001-07-11 勃勒柯研究有限公司 超声对比介质、含该介质的对比剂及方法
DE4406474A1 (de) * 1994-02-23 1995-08-24 Schering Ag Gas enthaltende Mikropartikel, diese enthaltende Mittel, deren Verwendung in der Ultraschalldiagnostik, sowie Verfahren zur Herstellung der Partikel und Mittel
DE69729088T2 (de) * 1996-03-05 2005-05-12 Acusphere, Inc., Cambridge Mikroverkapselte fluorierte gase zur anwendung als bilderzeugende mittel
US5976501A (en) * 1996-06-07 1999-11-02 Molecular Biosystems, Inc. Use of pressure resistant protein microspheres encapsulating gases as ultrasonic imaging agents for vascular perfusion
US5837221A (en) * 1996-07-29 1998-11-17 Acusphere, Inc. Polymer-lipid microencapsulated gases for use as imaging agents
US6045777A (en) * 1997-06-30 2000-04-04 Acusphere, Inc. Method for enhancing the echogenicity and decreasing the attenuation of microencapsulated gases

Also Published As

Publication number Publication date
RU2344833C2 (ru) 2009-01-27
JP4808214B2 (ja) 2011-11-02
IL213897A0 (en) 2011-07-31
JP2008501684A (ja) 2008-01-24
IL179594A0 (en) 2007-05-15
CN1993147A (zh) 2007-07-04
CN1993147B (zh) 2013-03-06
WO2005120587A1 (en) 2005-12-22
AU2004320514B2 (en) 2009-08-06
IL213897A (en) 2013-07-31
IL179594A (en) 2011-08-31
MXPA06014111A (es) 2007-03-07
CA2569134A1 (en) 2005-12-22
CA2569134C (en) 2010-11-23
RU2006147232A (ru) 2008-07-20
NO20070070L (no) 2007-03-05
AU2004320514B8 (en) 2009-08-27
AU2004320514A1 (en) 2005-12-22

Similar Documents

Publication Publication Date Title
ES2764472T3 (es) Agente de mejora del color de la piel y composición para mejorar el color de la piel
Dong et al. Intra-articular delivery of liposomal celecoxib–hyaluronate combination for the treatment of osteoarthritis in rabbit model
Fu et al. Homocysteine attenuates hemodynamic responses to nitric oxide in vivo
UA125747C2 (uk) Способи та композиції для лікування станів, пов'язаних із аномальною запальною відповіддю
Cavalcanti et al. Administration of reconstituted polyphenol oil bodies efficiently suppresses dendritic cell inflammatory pathways and acute intestinal inflammation
NO20075046L (no) Gastroresistente farmasoytiske formuleringer inneholdende rifaximin
BRPI0403935A (pt) Formas de dosagem de azitromicina com efeitos colaterais reduzidos
JP2014114290A (ja) 化粧料または皮膚外用剤
BRPI0513200A (pt) uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
NO20070070L (no) Ultralydkontrastmiddeldoseringsformulering
BRPI0414500A (pt) formulação farmacêutica composição para tratar uma infecção vaginal, e, métodos para tratar uma infecção vaginal, para estabilizar uma formulação de clindamicina, para tratar ou prevenir uma recorrência de uma infecção vaginal em uma paciente e para tratar condições vaginais
ES2361284T3 (es) Combinaciones terapéuticas.
GB0814302D0 (en) Compounds and methods
CN103025318B (zh) 含有喹啉酮衍生物、和硅油和/或硅油衍生物的悬浮液和块状组合物
HRP20230929T1 (hr) Stabilni pripravci semaglutida i njihova upotreba
US20160346211A1 (en) Bioerodible silicon-based delivery vehicles for delivery of therapeutic agents
Pascual et al. Mesoporous silica as multiple nanoparticles systems for inflammation imaging as nano-radiopharmaceuticals
BR0308229A (pt) Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio
WO2017131130A1 (ja) コンドロイチン硫酸及びヒアルロン酸を含有する安定化された水性組成物
BRPI0413474A (pt) uso de interferon e ribavirina e kit para uso no tratamento de infecções virais
DK1609483T3 (da) Kontrastmiddel til ultralyd
BR102012020929A2 (pt) Composição farmacêutica para a preparação de soluções de infusão de preparações antimicrobianas, seu processo de produção (variações)
Thorvaldson et al. Cytokine release by murine spleen cells following multiple low dose streptozotocin-induced diabetes and treatment with a TNFα transcriptional inhibitor
CN105250316A (zh) 一种含二联苯酚的抗癫痫药物组合
RU99113205A (ru) Состав на основе эмульсии перфторорганических соединений для медико-биологических целей

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]